Medicover Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Fredrik Rågmark
Chief executive officer
€2.6m
Total compensation
| CEO salary percentage | 39.0% |
| CEO tenure | 27.3yrs |
| CEO ownership | 1.0% |
| Management average tenure | 3.8yrs |
| Board average tenure | 14.8yrs |
Recent management updates
Recent updates
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects
Apr 22
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings
Apr 04Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price
Feb 11Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture
Dec 20Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Dec 02Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business
Sep 12Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet
Aug 21Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?
Jun 12Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends
May 27Is Medicover (STO:MCOV B) Using Too Much Debt?
May 12Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes
Feb 16Is Medicover (STO:MCOV B) Using Too Much Debt?
Jan 30Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?
Dec 30Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)
Dec 17Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger
Oct 30Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Oct 16Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?
Sep 09Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)
Jul 25Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Jul 12Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)
Jun 13At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?
May 29With EPS Growth And More, Medicover (STO:MCOV B) Is Interesting
Apr 20Medicover (STO:MCOV B) Could Easily Take On More Debt
Apr 08Medicover (STO:MCOV B) Is Doing The Right Things To Multiply Its Share Price
Mar 15Is Now The Time To Look At Buying Medicover AB (publ) (STO:MCOV B)?
Feb 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | €22m |
| Dec 31 2023 | n/a | n/a | €18m |
| Sep 30 2023 | n/a | n/a | €8m |
| Jun 30 2023 | n/a | n/a | €6m |
| Mar 31 2023 | n/a | n/a | €2m |
| Dec 31 2022 | €3m | €1m | €12m |
| Sep 30 2022 | n/a | n/a | €37m |
| Jun 30 2022 | n/a | n/a | €59m |
| Mar 31 2022 | n/a | n/a | €88m |
| Dec 31 2021 | €2m | €952k | €102m |
| Sep 30 2021 | n/a | n/a | €93m |
| Jun 30 2021 | n/a | n/a | €90m |
| Mar 31 2021 | n/a | n/a | €52m |
| Dec 31 2020 | €2m | €670k | €26m |
| Sep 30 2020 | n/a | n/a | €14m |
| Jun 30 2020 | n/a | n/a | €4m |
| Mar 31 2020 | n/a | n/a | €16m |
| Dec 31 2019 | €1m | €900k | €23m |
| Sep 30 2019 | n/a | n/a | €19m |
| Jun 30 2019 | n/a | n/a | €19m |
| Mar 31 2019 | n/a | n/a | €20m |
| Dec 31 2018 | €1m | €807k | €22m |
| Sep 30 2018 | n/a | n/a | €28m |
| Jun 30 2018 | n/a | n/a | €26m |
| Mar 31 2018 | n/a | n/a | €23m |
| Dec 31 2017 | €921k | €810k | €19m |
Compensation vs Market: Fredrik's total compensation ($USD2.78M) is above average for companies of similar size in the Swedish market ($USD789.18K).
Compensation vs Earnings: Fredrik's compensation has been consistent with company performance over the past year.
CEO
Fredrik Rågmark (60 yo)
27.3yrs
Tenure
€2,602,000
Compensation
Mr. Fredrik Ragmark serves as the Chief Executive Officer of Medicover AB (publ). Mr. Ragmark has been employed with Medicover since 1996. He serves as Managing Director and Board Member of Kalvskär AB.Fr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | no data | €2.60m | 1.04% € 273.7m | |
| Chief Financial Officer | no data | no data | 0.92% € 240.5m | |
| Chief Information Officer | 4.6yrs | no data | 0.0040% € 1.1m | |
| Head of Investor Relations | no data | no data | no data | |
| General Legal Counsel | no data | no data | 0.035% € 9.2m | |
| Chief Marketing Officer | no data | no data | no data | |
| Group Chief People Officer | less than a year | no data | no data | |
| Chief Operating Officer of Healthcare Services | 8.3yrs | no data | 0.49% € 127.2m | |
| Chief Operating Officer for Diagnostic Services | 2.9yrs | no data | 0.033% € 8.7m |
3.8yrs
Average Tenure
58yo
Average Age
Experienced Management: MCOV B's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 27.3yrs | €2.60m | 1.04% € 273.7m | |
| Independent Director | 17.3yrs | €54.60k | 1.22% € 318.4m | |
| Independent Chairman | 19.3yrs | €101.50k | 4.42% € 1.2b | |
| Independent Director | 23.3yrs | €66.20k | 0.060% € 15.7m | |
| Independent Director | 23.3yrs | €63.05k | 0.20% € 52.5m | |
| Independent Director | 9.3yrs | €78.30k | no data | |
| Independent Director | 2.1yrs | €59.85k | no data | |
| Independent Director | 2.1yrs | €63.05k | 0.0015% € 385.0k | |
| Independent Director | 12.3yrs | €54.60k | 2.6% € 679.7m | |
| Independent Director | 7.3yrs | €71.45k | 0.017% € 4.4m |
14.8yrs
Average Tenure
59.5yo
Average Age
Experienced Board: MCOV B's board of directors are seasoned and experienced ( 14.8 years average tenure).